SYBLEU INC.
SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications. It develops medical applications up to the point of completion of Phase I and or Phase II clinical trials after which the company sell or license developed applications or advance the application to Phase III clinical trials. SYBLEU INC. was incorporated in 2020 and … Read more
SYBLEU INC. (SYBE) - Total Assets
Latest total assets as of December 2023: $304.15K USD
Based on the latest financial reports, SYBLEU INC. (SYBE) holds total assets worth $304.15K USD as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SYBLEU INC. - Total Assets Trend (2019–2022)
This chart illustrates how SYBLEU INC.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
SYBLEU INC. - Asset Composition Analysis
Current Asset Composition (December 2022)
SYBLEU INC.'s total assets of $304.15K consist of 87.0% current assets and 13.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 60.4% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $300.00K | 491.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2022)
This chart illustrates how SYBLEU INC.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SYBLEU INC.'s current assets represent 87.0% of total assets in 2022, a decrease from 100.0% in 2019.
- Cash Position: Cash and equivalents constituted 60.4% of total assets in 2022, up from 59.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 491.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 491.8% of total assets.
SYBLEU INC. Competitors by Total Assets
Key competitors of SYBLEU INC. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
SYBLEU INC. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - SYBLEU INC. generates 0.19x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - SYBLEU INC. is currently not profitable relative to its asset base.
SYBLEU INC. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.04 | 0.31 | 0.32 |
| Quick Ratio | 0.04 | 0.31 | 0.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-238.80K | $ -118.20K | $ -113.95K |
SYBLEU INC. - Advanced Valuation Insights
This section examines the relationship between SYBLEU INC.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 2.75 |
| Asset Growth Rate (YoY) | -20.1% |
| Total Assets | $61.00K |
| Market Capitalization | $167.95K USD |
Valuation Analysis
Premium Asset Valuation: The market values SYBLEU INC.'s assets at a significant premium ( 2.75x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: SYBLEU INC.'s assets decreased by 20.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for SYBLEU INC. (2019–2022)
The table below shows the annual total assets of SYBLEU INC. from 2019 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $61.00K | -20.14% |
| 2021-12-31 | $76.38K | -61.72% |
| 2020-12-31 | $199.55K | +2233.88% |
| 2019-12-31 | $8.55K | -- |